유전체 공학 편집 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global genome engineering editing market size is expected to reach USD 57.23 Billion in 2034 from USD 11.34 Billion in 2025, growing at a CAGR of 19.71 during 2026-2034.This market is expanding rapidly as breakthroughs in molecular biology enable precise modification of genetic material across healthcare, agriculture, and industrial biotechnology. Genome engineering and editing technologies such as CRISPR-Cas systems, TALENs, and zinc finger nucleases are transforming research and therapeutic development by allowing targeted gene insertion, deletion, or correction. The rising focus on personalized medicine and the need to address genetic disorders are significantly driving demand. Additionally, increasing investments from pharmaceutical companies and research institutions are accelerating innovation and adoption of genome editing platforms.

Key growth drivers include advancements in gene-editing tools and the increasing prevalence of genetic and chronic diseases. Researchers are leveraging these technologies to develop novel therapies, including gene therapies and cell-based treatments. The agricultural sector is also contributing to market growth by using genome editing to develop crops with improved yield, resistance, and nutritional value. Furthermore, regulatory support in certain regions and the expansion of clinical trials are encouraging the commercialization of genome-editing applications.

Future prospects for this market remain highly promising, with continued innovation expected to expand its applications and improve efficiency. The development of safer and more precise editing techniques will address ethical and safety concerns. Emerging markets are likely to witness increased adoption due to growing research capabilities. As biotechnology continues to evolve, the genome engineering editing market is poised for sustained expansion and transformative impact across industries.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product and Service Type

• Reagents and Consumables
• Software and Systems
• Services

By Technology

• Restriction Enzymes
• Zinc-Finger Nucleases (ZFN)
• Transcription activator-like effector nucleases (TALEN)
• Clustered regularly interspaced short palindromic repeats (CRISPR)
• Antisense
• Others

By Delivery Method

• Ex-vivo
• In-vivo

By Mode

• Contract
• In-House

By Application

• Animal Genetic Engineering
• Plant Genetic Engineering
• Drug Discovery and Development
• Diagnostic Applications
• Cell Line Engineering
• Others

By End-User

• Biotech and Pharma Companies
• Government and Academic Research Institutes
• Contract Research Organizations (CROs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Merck KGaA, Integrated DNA Technologies Inc., New England Biolabs Inc., Sangamo Biosciences Inc., Genscript Biotech Corp, Agilent Technologies Inc., Creative Biogene, Intellia Therapeutics Inc., Lonza Group

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOME ENGINEERING EDITING MARKET: BY PRODUCT AND SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service Type
• 4.2. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software and Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOME ENGINEERING EDITING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Restriction Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Zinc-Finger Nucleases (ZFN) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transcription activator-like effector nucleases (TALEN) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Clustered regularly interspaced short palindromic repeats (CRISPR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Antisense Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOME ENGINEERING EDITING MARKET: BY DELIVERY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Delivery Method
• 6.2. Ex-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. In-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOME ENGINEERING EDITING MARKET: BY MODE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Mode
• 7.2. Contract Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. In-House Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOME ENGINEERING EDITING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Animal Genetic Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Plant Genetic Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Diagnostic Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Cell Line Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENOME ENGINEERING EDITING MARKET: BY END-USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End-user
• 9.2. Biotech and Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Government and Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Contract Research Organizations (CROs) Estimates and Forecasts

By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENOME ENGINEERING EDITING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product And Service Type
  • 10.2.2 By Technology
  • 10.2.3 By Delivery Method
  • 10.2.4 By Mode
  • 10.2.5 By Application
  • 10.2.6 By End-user
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product And Service Type
  • 10.3.2 By Technology
  • 10.3.3 By Delivery Method
  • 10.3.4 By Mode
  • 10.3.5 By Application
  • 10.3.6 By End-user
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product And Service Type
  • 10.4.2 By Technology
  • 10.4.3 By Delivery Method
  • 10.4.4 By Mode
  • 10.4.5 By Application
  • 10.4.6 By End-user
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product And Service Type
  • 10.5.2 By Technology
  • 10.5.3 By Delivery Method
  • 10.5.4 By Mode
  • 10.5.5 By Application
  • 10.5.6 By End-user
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast,
• 2022-2034 (USD MN)
• 10.6.1 By Product And Service Type
• 10.6.2 By Technology
• 10.6.3 By Delivery Method
• 10.6.4 By Mode
• 10.6.5 By Application
• 10.6.6 By End-user
• 10.6.7 Saudi Arabia
• 10.6.8 UAE
• 10.6.9 Israel
• 10.6.10 South Africa
• 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENOME ENGINEERING EDITING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Thermo Fisher Scientific Inc
  • 12.2.2 Merck KGaA
  • 12.2.3 Integrated DNA Technologies Inc
  • 12.2.4 New England Biolabs Inc
  • 12.2.5 Sangamo Biosciences Inc
  • 12.2.6 Genscript Biotech Corp
  • 12.2.7 Agilent Technologies Inc
  • 12.2.8 Creative Biogene
  • 12.2.9 Intellia Therapeutics Inc
  • 12.2.10 Lonza Group